CDC evaluation of the efficacy of monovalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection in 3 to 5-year-olds - Earth News Report
In a recent study published in the Morbidity and Mortality Weekly Report by the United States Centers for Disease Control and Prevention (CDC), researchers estimate the efficacy of the monovalent messenger ribonucleic acid (mRNA) coronavirus disease 2019 (COVID-19) in preventing symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in the pediatric population between the
